CoChat
Sign Up
Cited by 70

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas

Giatromanolaki, Alexandra, Koukourakis, Michael I., Koutsopoulos, Anastasios, Chloropoulou, Pelagia, Liberis, Vasileios, Sivridis, Efthimios·2011·Gynecologic Oncology
DOI 10.1016/j.ygyno.2011.06.023
Open this paper in CoChat — free account

Abstract

Objective To investigate the prognostic role of Beclin 1 in endometrial adenocarcinomas of the endometrioid cell type. Beclin 1 is a known tumor suppressor gene, but its function may be altered under conditions of an accelerated autophagic activity, which provides additional energy to proliferating cells by recycling defective organelles and long-lived cytoplasmic proteins. Materials and methods One hundred and fifty-five endometrioid adenocarcinomas were investigated for their autophagic activity using the monoclonal antibody Beclin 1 and an automated immunohistochemical technique. The extent of Beclin 1 expression was evaluated on a three-tier scale as follows: low ( 50% positive tumor cells). The results were correlated with the degree of tumor differentiation, the depth of myometrial invasion and the overall 5-year survival. In addition, the endometrial tumors were immunostained with the hypoxia inducible factor 1α (HIF1α) and their expression was related to Beclin 1. Results A high Beclin 1 reactivity occurred in 18.1% of endometrial adenocarcinomas studied and was associated with high tumor grade, high myometrial invasion and a poor 5-year survival. It was also correlated positively with HIF1α. Of the remaining adenocarcinomas 29.7% were of intermediate Beclin 1 reactivity and 52.2% of low, but correlations with prognostic factors were insignificant. Conclusion An increased Beclin 1 expression is connected with the most aggressive endometrioid adenocarcinomas, probably…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ygyno.2011.06.023

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 32

  1. Klionsky, 2000, Autophagy as a regulated pathway of cellular degradation, Science, 290, 1717, 10.1126/science.290.5497.1717 · DOI
  2. Rosenfeldt, 2011, The multiple roles of autophagy in cancer, Carcinogenesis, 10.1093/carcin/bgr031 · DOI
  3. White, 2009, The double-edged sword of autophagy modulation in cancer, Clin Cancer Res, 15, 5308, 10.1158/1078-0432.CCR-07-5023 · DOI
  4. Cao, 2007, Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein, Cell Res, 17, 839, 10.1038/cr.2007.78 · DOI · Paper page
  5. Sivridis, 2011, Autophagy in endometrial carcinomas and prognostic relevance of ‘stone-like’ structures (SLS): what is destined for the atypical endometrial hyperplasia?, Autophagy, 7, 74, 10.4161/auto.7.1.13947 · DOI · Paper page
  6. Creasman, 1989, Announcement. FIGO stages—1988 revision, Gynecol Oncol, 35, 125
  7. Zaino, 1995, The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study, Cancer, 75, 81, 10.1002/1097-0142(19950101)75:1<81::AID-CNCR2820750114>3.0.CO;2-F · DOI
  8. Lotocki, 1983, Stage I endometrial adenocarcinoma: treatment results in 835 patients, Am J Obstet Gynecol, 146, 141, 10.1016/0002-9378(83)91042-6 · DOI
  9. Carcinoma of the endometrium, 1993, ACOG Technical Bulletin Number 162–December 1991, Int J Gynaecol Obstet, 40, 255, 10.1016/0020-7292(93)90842-K · DOI
  10. Noyes, 1950, Dating the endometrial biopsy, Fertil Steril, 1, 3, 10.1016/S0015-0282(16)30062-0 · DOI
  11. Biesterfeld, 2003, Analysis of the reliability of manual and automated immunohistochemical staining procedures. A pilot study, Anal Quant Cytol Histol, 25, 90
  12. Lu, 2009, Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections, Appl Immunohistochem Mol Morphol, 17, 158, 10.1097/PAI.0b013e318185d1b5 · DOI
  13. Arbogast, 2011, Automated ERCC1 immunohistochemistry in non-small cell lung cancer: comparison of anti-ERCC1 antibodies 8F1, D-10, and FL-297, Appl Immunohistochem Mol Morphol, 19, 99, 10.1097/PAI.0b013e3181f1feeb · DOI
  14. Sivridis, 2002, Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma, Cancer, 95, 1055, 10.1002/cncr.10774 · DOI · Paper page
  15. Ren, 2010, Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis. 1, Arch Gynecol Obstet, 282, 401, 10.1007/s00404-009-1280-0 · DOI
  16. John, 2008, Regulation of estrogenic effects by beclin 1 in breast cancer cells, Cancer Res, 68, 7855, 10.1158/0008-5472.CAN-07-5875 · DOI
  17. Koukourakis, 2010, Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia, Br J Cancer, 103, 1209, 10.1038/sj.bjc.6605904 · DOI
  18. Li, 2009, The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers, Autophagy, 5, 303, 10.4161/auto.5.3.7491 · DOI
  19. Huang, 2010, Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type, Autophagy, 6, 777, 10.4161/auto.6.6.12784 · DOI · Paper page
  20. Pirtoli, 2009, The prognostic role of Beclin 1 protein expression in high-grade gliomas, Autophagy, 5, 930, 10.4161/auto.5.7.9227 · DOI
  21. Shi, 2009, Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma, Autophagy, 5, 380, 10.4161/auto.5.3.7658 · DOI
  22. Wan, 2010, Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma, Autophagy, 6, 395, 10.4161/auto.6.3.11303 · DOI
  23. Zhu, 2009, Yang JM Regulation of autophagy by a Beclin 1-targeted microRNA, miR-30a, in cancer cells, Autophagy, 5, 816, 10.4161/auto.9064 · DOI
  24. Mazure, 2009, Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia, Autophagy, 5, 868, 10.4161/auto.9042 · DOI
  25. Azad, 2008, Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3, Autophagy, 4, 195, 10.4161/auto.5278 · DOI
  26. Sivridis, 2011, Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1, Melanoma Res, 21, 188, 10.1097/CMR.0b013e328346612c · DOI · Paper page
  27. Yeh, 2010, Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy, Life Sci, 86, 115, 10.1016/j.lfs.2009.11.022 · DOI
  28. Rzymski, 2010, Regulation of autophagy by ATF4 in response to severe hypoxia, Oncogene, 29, 4424, 10.1038/onc.2010.191 · DOI
  29. Mazure, 2009, Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia, Autophagy, 5, 868, 10.4161/auto.9042 · DOI
  30. Zhao, 2011, Autophagy regulates hypoxia induced osteoclastogenesis through the HIF-1α/BNIP3 signaling pathway, J Cell Physiol, 10.1002/jcp.22768 · DOI · Paper page
  31. John, 2008, Regulation of estrogenic effects by beclin 1 in breast cancer cells, Cancer Res, 68, 7855, 10.1158/0008-5472.CAN-07-5875 · DOI
  32. Ren, 2010, Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis, Arch Gynecol Obstet, 282, 401, 10.1007/s00404-009-1280-0 · DOI

Cited by

Sorted by citations

See all 70

Metadata

Authors
Giatromanolaki, A., Koukourakis, M. I., Koutsopoulos, A., Chloropoulou, P., Liberis, V., & Sivridis, E.
Venue
Gynecologic Oncology
Publisher
Elsevier BV
Published
2011-10
Volume
123
Issue
1
Pages
147-151
ISSN
0090-8258
DOI
10.1016/j.ygyno.2011.06.023
Cited by
70
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review